Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324. Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380. Case and Commentary May 2019 How Should Physicians Respond to Requests for LVAD Removal? Larry A. Allen, MD, MHS Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward. AMA J Ethics. 2019;21(5):E394-400. doi: 10.1001/amajethics.2019.394. Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806. Case and Commentary Apr 2020 What Should an Anesthesiologist and Surgeon Do When They Disagree About Terms of Perioperative DNR Suspension? Alexander E. Loeb, MD, Shawn Y. Jia, MD, and Casey J. Humbyrd, MD Using alternative anesthesia techniques requires collaborative decision making that expresses a patient’s best interest. AMA J Ethics. 2020;22(4):E283-290. doi: 10.1001/amajethics.2020.283. Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020;22(5):E352-357. doi: 10.1001/amajethics.2020.352. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324.
Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380.
Case and Commentary May 2019 How Should Physicians Respond to Requests for LVAD Removal? Larry A. Allen, MD, MHS Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward. AMA J Ethics. 2019;21(5):E394-400. doi: 10.1001/amajethics.2019.394.
Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806.
Case and Commentary Apr 2020 What Should an Anesthesiologist and Surgeon Do When They Disagree About Terms of Perioperative DNR Suspension? Alexander E. Loeb, MD, Shawn Y. Jia, MD, and Casey J. Humbyrd, MD Using alternative anesthesia techniques requires collaborative decision making that expresses a patient’s best interest. AMA J Ethics. 2020;22(4):E283-290. doi: 10.1001/amajethics.2020.283.
Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020;22(5):E352-357. doi: 10.1001/amajethics.2020.352.